An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South

Sponsor
Rhode Island Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05087680
Collaborator
University of Mississippi Medical Center (Other)
66
1
2
33
2

Study Details

Study Description

Brief Summary

Investigators will use a generalized framework for the adaptation of EBIs to inform the development of a brief Acceptance and Commitment Therapy (ACT)-based culturally appropriate pre-exposure prophylaxis (PrEP) intervention tailored to young Black men who have sex with men (YBMSM), named ACTPrEP.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: ACTPrEP
  • Behavioral: Enhanced Standard of Care
N/A

Detailed Description

Investigators will use a generalized framework for the adaptation of EBIs to inform the development of a brief Acceptance and Commitment Therapy (ACT)-based culturally appropriate pre-exposure prophylaxis (PrEP) intervention tailored to young Black men who have sex with men (YBMSM), named ACTPrEP.

Specific Aim 1) Gather data from YBMSM (n = 20) and clinic staff (n = 10) through in-depth interviews to assess quantitative measures, intervention design, and experiences most relevant to PrEP engagement.

Specific Aim 2) Develop ACTPrEP utilizing Aim 1 data, working iteratively with experts, and an intervention "run through" with a sample of participants.

CLINICAL TRIAL IS AIM 3 ONLY

Specific Aim 3) Evaluate ACTPrEP. Enroll 66 participants. Primary outcomes will be feasibility (measured by percentage eligible, consented, randomized, and retained) and acceptability (measured by the Client Satisfaction Questionnaire). Secondary outcomes will compare ACTPrEP vs. enhanced standard of care condition (ESOC) on behavior outcomes (uptake, adherence, and PrEP persistence) and possible mediators over the course of 24 weeks. Barriers and facilitators to implementing ACTPrEP will be assessed with post-RCT qualitative interviews using the i-PARIHS framework.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South
Anticipated Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control Group

Control group will include one 30-minute PrEP education session.

Behavioral: Enhanced Standard of Care
Enhanced Standard of Care (ESOC) will include one 30-minute PrEP education session.

Experimental: ACTPrEP

ACTPrEP will include a 60-minute initial session and 30-minute sessions at 2, 6, and 12 weeks.

Behavioral: ACTPrEP
ACTPrEP will include a 60-minute initial session and a series of 30-minute follow-up sessions. Sessions will focus on the Thoughts, Emotions, Associations, Memories, and Sensations (TEAMS) relevant to PrEP uptake and adherence.

Outcome Measures

Primary Outcome Measures

  1. ACTPrEP Feasibility [12 week visit]

    ACTPrEP feasibility is measured by percentage of participants retained in the study.

  2. ACTPrEP Acceptability [12 week visit]

    Acceptability is measured with the Client Satisfaction Questionnaire.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 34 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • English speaking

  • Between 18-34 years old

  • Male sex assigned at birth

  • Identify as African American/Black

  • Not enrolled in another PrEP related study

  • Able to give consent

  • Not taken PrEP in past 3 months

  • Report having sex with a man in the past 3 months

  • PrEP-eligible according to CDC guidelines

Exclusion Criteria:
  • Participating in another PrEP study

  • Unable to provide consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Univeristy of Mississippi Medical Center Jackson Mississippi United States 39216

Sponsors and Collaborators

  • Rhode Island Hospital
  • University of Mississippi Medical Center

Investigators

  • Principal Investigator: Trisha Arnold, PhD, Rhode Island Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rhode Island Hospital
ClinicalTrials.gov Identifier:
NCT05087680
Other Study ID Numbers:
  • ACTPrEP
First Posted:
Oct 21, 2021
Last Update Posted:
May 3, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Rhode Island Hospital

Study Results

No Results Posted as of May 3, 2022